Phase I, dose-escalation study of BIIB022 (anti-IGF-1R antibody) in advanced solid tumors

被引：0
|
作者：
von Mehren, M.
Britten, C.
Lear, K.
Camidge, D. R.
Wainberg, Z. A.
Pieslor, P. C.
Darif, M.
Harris, S.
Balogh, K.
Leong, S.
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Univ Calif Los Angeles, Clin Res Unit, Los Angeles, CA USA
[3] Univ Colorado Denver, Aurora, CO USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[5] Biogen Idec Inc, San Diego, CA USA
[6] Univ Colorado, Ctr Canc, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2612
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
    Macaulay, Valentine M.
    Middleton, Mark R.
    Eckhardt, S. Gail
    Rudin, Charles M.
    Juergens, Rosalyn A.
    Gedrich, Richard
    Gogov, Sven
    McCarthy, Sean
    Poondru, Srinivasu
    Stephens, Andrew W.
    Gadgeel, Shirish M.
    CLINICAL CANCER RESEARCH, 2016, 22 (12) : 2897 - 2907
  • [42] Phase I dose-escalation study of E7080, a multikinase inhibitor, in patients with advanced solid tumors
    Nemunaitis, J. J.
    Senzer, N. N.
    Kurzrock, R.
    Ng, C. S.
    Das, A.
    Atienza, R. S.
    Zang, E. A.
    Jansen, M.
    Ashworth, S.
    Hong, D. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [43] A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors
    Tracy Murray Stewart
    Apurva A. Desai
    Michael L. Fitzgerald
    Laurence J. Marton
    Robert A. Casero
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 1089 - 1096
  • [44] Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors
    Brenner, Andrew J.
    Cohen, Yael C.
    Breitbart, Eyal
    Bangio, Livnat
    Sarantopoulos, John
    Giles, Francis J.
    Borden, Ernest C.
    Harats, Dror
    Triozzi, Pierre L.
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3996 - 4007
  • [45] A phase I dose-escalation study of the polyamine analog PG-11047 in patients with advanced solid tumors
    Stewart, Tracy Murray
    Desai, Apurva A.
    Fitzgerald, Michael L.
    Marton, Laurence J.
    Casero, Robert A., Jr.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (06) : 1089 - 1096
  • [46] Capecitabine (Xeloda®) in combination with oxaliplatin:: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors
    Díaz-Rubio, E
    Evans, TRJ
    Tabernero, J
    Cassidy, J
    Sastre, J
    Eatock, M
    Bisset, D
    Regueiro, P
    Baselga, J
    ANNALS OF ONCOLOGY, 2002, 13 (04) : 558 - 565
  • [47] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Véronique Diéras
    Thomas Bachelot
    Mario Campone
    Nicolas Isambert
    Florence Joly
    Christophe Le Tourneau
    Philippe Cassier
    Emmanuelle Bompas
    Pierre Fumoleau
    Sabine Noal
    Christine Orsini
    Marta Jimenez
    Diane Charlotte Imbs
    Etienne Chatelut
    Oncology and Therapy, 2016, 4 (2) : 211 - 223
  • [48] Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors
    Bendell, JC
    Eder, JP
    Clark, JW
    Fidias, P
    Lynch, TJ
    Seiden, MV
    Ryan, DP
    CANCER, 2005, 103 (09) : 1925 - 1931
  • [49] A Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A UNICANCER Study
    Dieras, Veronique
    Bachelot, Thomas
    Campone, Mario
    Isambert, Nicolas
    Joly, Florence
    Le Tourneau, Christophe
    Cassier, Philippe
    Bompas, Emmanuelle
    Fumoleau, Pierre
    Noal, Sabine
    Orsini, Christine
    Jimenez, Marta
    Imbs, Diane Charlotte
    Chatelut, Etienne
    ONCOLOGY AND THERAPY, 2016, 4 (02) : 211 - 223
  • [50] Phase I dose-escalation study of capmatinib (INC280) in Japanese patients with advanced solid tumors
    Esaki, Taito
    Hirai, Fumihiko
    Makiyama, Akitaka
    Seto, Takashi
    Bando, Hideaki
    Naito, Yoichi
    Yoh, Kiyotaka
    Ishihara, Kae
    Kakizume, Tomoyuki
    Natsume, Kazuto
    Myers, Andrea
    Doi, Toshihiko
    CANCER SCIENCE, 2019, 110 (04) : 1340 - 1351
12345